FDA.reportPublic FDA data

inert ingredients 1 MG Chewable Tablet

RxCUI
2539227
RxNorm name
inert ingredients 1 MG Chewable Tablet
Display name
inert ingredients 1 MG Chewable Tablet
Full name
inert ingredients 1 MG Chewable Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:16

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TyblumeLEVONORGESTREL AND ETHINYL ESTRADIOLExeltis USA, Inc.b2482d51-d606-4aaa-8af4-19e4fe2f88722026-08-27Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2539227

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
b2482d51-d606-4aaa-8af4-19e4fe2f8872inert ingredients 1 MG Chewable Tablet [PSN] · inert ingredients 1 MG Chewable Tablet [SCD]26These highlights do not include all the information needed to use TYBLUME safely and effectively. See full prescribing information for TYBLUME. TYBLUME (levonorgestrel and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1968 (norgestrel and ethinyl estradiol)20230212